Skip to main content
SpringerLink
Log in

Pharmacokinetics of Gentamicin in Newborns with Moderate-to-Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To investigate gentamicin pharmacokinetics in neonates with moderate-to-severe hypoxic-ischemic encephalopathy (HIE) who underwent therapeutic hypothermia (TH).

Methods

Data were collected retrospectively from infants admitted between January 2007 and February 2011. Gentamicin was given at 2.5 mg/kg/dose q12h intravenously. Infants not eligible for TH underwent therapeutic normothermia (TN). After reviewing the data which showed >85 % of infants undergoing TH had gentamicin trough concentration >2 µg/ml at steady state, the gentamicin level monitoring protocol was modified since March 2011.

Results

In the initial retrospective study, 15 TN infants were compared with 19 TH infants. There was significant difference in median gentamicin half-life (7.01 vs. 9.57 h). A higher proportion of infants in the TH group required dosage adjustment (8/15 vs. 17/19). After March 2011, gentamicin level taken 12-h post 1st dose was measured routinely and 18/22 infants had trough gentamicin levels >2 µg/ml. Their dosing intervals were extended to Q18h or beyond.

Conclusions

Infants with moderate-to-severe HIE who undergo TH may exhibit changes in the pharmacokinetic properties of gentamicin compared to infants who undergo TN. By measuring gentamicin level at 12-h after the first dose of 2.5 mg/kg/dose, appropriate dosing interval can be determined and the duration of exposure to toxic gentamicin level can be reduced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med. 2011;165:692–700.

    Article  PubMed  Google Scholar 

  2. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–84.

    Article  CAS  PubMed  Google Scholar 

  3. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349–58.

    Article  CAS  PubMed  Google Scholar 

  4. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663–70.

    Article  PubMed  Google Scholar 

  5. Saez-Llorens X, McCracken GHJ. Clinical pharmacology of antibacterial agents. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 1223–67.

  6. Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980;302:1106–9.

    Article  CAS  PubMed  Google Scholar 

  7. Moore RD, Smith CR, Lietman PS. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis. 1984;149:23–30.

    Article  CAS  PubMed  Google Scholar 

  8. Brummett RE, Fox KE. Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother. 1989;33:797–800.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Smit E, Liu X, Gill H, Sabir H, Jary S, Thoresen M. Factors associated with permanent hearing impairment in infants treated with therapeutic hypothermia. J Pediatr. 2013;163:995–1000.

    Article  PubMed  Google Scholar 

  10. Begg EJ, Vella-Brincat JW, Robertshawe B, McMurtrie MJ, Kirkpatrick CM, Darlow B. Eight years’ experience of an extended-interval dosing protocol for gentamicin in neonates. J Antimicrob Chemother. 2009;63:1043–9.

    Article  CAS  PubMed  Google Scholar 

  11. Rao SC, Srinivasjois R, Hagan R, Ahmed M. 2011. Cochrane Database Syst Rev. 2011;11:CD005091.

    PubMed  Google Scholar 

  12. Darmstadt GL, Miller-Bell M, Batra M, Law P, Law K. Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries. J Health Popul Nutr. 2008;26:163–82.

    PubMed Central  PubMed  Google Scholar 

  13. Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM. Once- versus twice-daily gentamicin dosing in neonates >/=34 Weeks’ gestation: cost-effectiveness analyses. Pediatrics. 1999;103:594–8.

    Article  CAS  PubMed  Google Scholar 

  14. Lundergan FS, Glasscock GF, Kim EH, Cohen RS. Once-daily gentamicin dosing in newborn infants. Pediatrics. 1999;103:1228–34.

    Article  CAS  PubMed  Google Scholar 

  15. Nestaas E, Bangstad HJ, Sandvik L, Wathne KO. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2005;90:F294–300.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Bueva A, Guignard JP. Renal function in preterm neonates. Pediatr Res. 1994;36:572–7.

    Article  CAS  PubMed  Google Scholar 

  17. Svenningsen NW. Single injection polyfructosan clearance in normal and asphyxiated neonates. Acta Paediatr Scand. 1975;64:87–95.

    Article  CAS  PubMed  Google Scholar 

  18. Liu X, Borooah M, Stone J, Chakkarapani E, Thoresen M. Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. Pediatrics. 2009;124:310–5.

    Article  PubMed  Google Scholar 

  19. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013;33:718–26.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Mark LF, Solomon A, Northington FJ, Lee CK. Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia. Ther Drug Monit. 2013;35:217–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm. 1976;4:183–95.

    Article  CAS  PubMed  Google Scholar 

  22. Edwards MS. Antibacterial therapy in pregnancy and neonates. Clin Perinatol. 1997;24:251–66.

    CAS  PubMed  Google Scholar 

  23. Lanao JM, Calvo MV, Mesa JA, Martin-Suarez A, Carbajosa MT, Miguelez F, et al. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. J Antimicrob Chemother. 2004;54:193–8.

    Article  CAS  PubMed  Google Scholar 

  24. Pacifici GM. Clinical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol. 2009;65:419–27.

    Article  CAS  PubMed  Google Scholar 

  25. Gilbert DN, Leggett JE. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 1. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 359–84.

  26. Friedman CA, Parks BR, Rawson JE. Gentamicin disposition in asphyxiated newborns: relationship to mean arterial blood pressure and urine output. Pediatr Pharmacol (New York). 1982;2:189–97.

    CAS  Google Scholar 

  27. Koren G, Barker C, Bohn D, Kent G, Biggar WD. Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets. Crit Care Med. 1985;13:844–7.

    Article  CAS  PubMed  Google Scholar 

  28. Satas S, Hoem NO, Melby K, Porter H, Lindgren CG, Whitelaw A, et al. Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs. Biol Neonate. 2000;77:50–7.

    Article  CAS  PubMed  Google Scholar 

  29. NeoFax®. Gentamicin Dosing Guideline: Truven Health Analytics Inc.; 2013.

  30. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, et al. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013;33:778–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. John Smyth and Ms. Ruth Milner for their expert comments.

Conflict of Interest

None.

Source of Funding

None.

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, University of British Columbia, 1R46A - 4480 Oak Street, Vancouver, V6H 3V4, BC, Canada

    Joseph Y. Ting, Eddie Kwan, Al McDougal & Horacio Osiovich

Authors
  1. Joseph Y. Ting
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eddie Kwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Al McDougal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Horacio Osiovich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph Y. Ting.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ting, J.Y., Kwan, E., McDougal, A. et al. Pharmacokinetics of Gentamicin in Newborns with Moderate-to-Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia. Indian J Pediatr 82, 119–125 (2015). https://doi.org/10.1007/s12098-014-1527-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-014-1527-z

Keywords

Search

Navigation